Skip to content

Evaluation of Web-based Management Strategy among Population with High-risk of Cardiovascular Disease

Environment, Epigenetics and Early Intervention of Hypertension and Coronary Heart Disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019357
Enrollment
Unknown
Registered
2018-11-07
Start date
2018-11-15
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High risk of Cardiovascular Disease

Interventions

Common Intervention among Diabetic Individuals:Common Management
Intensive Intervention among Individuals with Dyslipidemia:Web-based intensive management
Intensive Intervention among Hypertensive Individuals:Web-based intensive management
Common Intervention among Hypertensive Individuals:Common Management
Intensive Intervention among Diabetic Individuals:Web-based intensive management
Common Intervention among Individuals with Dyslipidemia:Common Management
Intensive Intervention among Obese Individuals:Web-based intensive management
Common Intervention among Obese Individuals:Common Management

Sponsors

Fuwai Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The subjects should be 35-74 years old and have been living the local community at least 6 months who agree to set up personal health records and receive health management. The subject is eligible if he or she has at least one of the 4 following risk factors: 1) Hypertension (SBP/DBP=140/90 mmHg or taking medication therapy); 2) Diabetes (Fasting serum glucose =7 mmol/L or taking medication therapy); 3) Dyslipidemia (TC=6.22 mmol/L, LDL-C=4.14 mmol/L, HDL-C<1.04 mmol/L, TG=2.26 mmol/L or taking medication therapy) 4) Obesity (BMI=28kg/m2)

Exclusion criteria

Exclusion criteria: The subject should be excluded from the project if he or she has any one of the following items: 1) stroke; 2) myocardial infarction or coronary heart disease; 3) severe cardiac insufficiency with NYHA III or IV; 4) aneurysm or dissecting aneurysm; 5) Atherosclerosis Obliterans (ASO); 6) chronic obstructive pulmonary disease or pulmonary heart disease; 7) secondary hypertension, thyroid diseases, hypothalamic-pituitary diseases, adrenal diseases or other endocrine diseases; 8) any acute problems to be treated such as acute infection, hypertensive crisis, diabetic ketoacidosis, etc.; 9) severe abnormal hepatic and renal function, autoimmune diseases, or other fatal diseases; 10) cancer; 11) being pregnant or lactating women; 12) mental disorders, alcoholism, acrasia, or problem with inexpressibility; 13) other incompliance problems such as metal impairment or physical disability.

Design outcomes

Primary

MeasureTime frame
Control Rate;Systolic Blood Pressure;10-year risk;Total Cholesterol;Blood Glucose;Body Mass Index;

Secondary

MeasureTime frame
Lifetime;KAP Score;Diastolic Blood Pressure;Low Density Lipoprotein Cholesterol;High Lipoprotein Cholesterol;Triglyceride;Waist Circumference;Body Fat Percentage;Ankle-brachial Index;Carotid intima-media Thickness;Carotid Plaque;

Countries

China

Contacts

Public ContactDongfeng Gu

Fuwai Hospital, Chinese Academy of Medical Sciences

gudongfeng@vip.sina.com+86 010-88398630

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026